call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Cell And Gene Therapy Drug Delivery Devices Market
Inquire Before Buying Request for Sample

Cell And Gene Therapy Drug Delivery Devices Market

Home Medical Devices Cell And Gene Therapy Drug Delivery Devices Market

SPECIAL OFFER : 25% Super Discount For All !

Cell and Gene Therapy Drug Delivery Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-Filled Syringe, Infusion Bag); By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticle); By Commercialized Drug (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis); By End User (Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospital & Clinic); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: December 2023
  • Report ID: BWC231042
  • Available Format: PDF
  • Page: 400

Report Overview

A growing focus on and increasing investments in the R&D of efficient therapies for the treatment and management of the increasing prevalence of chronic diseases are projected to propel the expansion of the Global Cell and Gene Therapy Drug Delivery Devices Market during the forecast period between 2023 and 2029.

Global Cell and Gene Therapy Drug Delivery Devices Market - Industry Trends & Forecast Report, 2029

Global Cell and Gene Therapy Drug Delivery Devices Market size was estimated at USD 99.97 thousand in 2022. During the forecast period between 2023 and 2029, the size of Global Cell and Gene Therapy Drug Delivery Devices Market is projected to grow at a CAGR of 16.79% reaching a value of USD 253.69 thousand by 2029. Major growth drivers for the Global Cell and Gene Therapy Drug Delivery Devices Market include an increasing prevalence of cancer and chronic diseases, increasing investments in the sector, the imperative to innovate treatments for rare diseases, augmented investments in biopharmaceutical R&D programs, and a rising number of FDA approvals and clinical trials. Several emerging approaches in cell and gene-based therapies leverage biological engineering to enhance the immune system's ability to combat diseases while preserving the health of surrounding tissues. For instance, antibody-based therapies can enhance the effectiveness of T-cells by intensifying their interactions with cancer cells. Other modifications, such as enhancing the complexity of CAR-T and cancer cell interactions, contribute to refining T-cells' ability to target cancer, thereby reducing harm to normal cells. The rapidly aging global population, coupled with a growing incidence of cancer cases and genetic disorders globally, is projected to result in a significantly increased demand for drug delivery devices within the cell and gene therapy market. Also, substantial investments by companies in the R&D of cell and gene therapies, along with associated drug delivery devices, underscore the industry's commitment to advancements. The upward trajectory of clinical trials for various genetic and chronic diseases in recent years is poised to propel the cell and gene therapy drug delivery devices market during the period in analysis.

Cell and Gene Therapy Drug Delivery Devices Market

Global Cell and Gene Therapy Drug Delivery Devices Market – Overview

The cell and gene therapy drug delivery industry is a transformative sector with its full potential still unfolding. This field involves extracting cells, proteins, or genetic material (DNA) from donors and modifying them for highly personalized therapy, potentially offering longer-lasting effects compared to traditional medicines. Noteworthy within this industry are CAR-T cell-based medicines, combining both cell and gene therapy. Key market players are actively investing in research and development to enhance and introduce new products that address crucial patient needs. The industry is at an exciting stage, and advancements in cell and gene therapy hold promise for personalized and more effective medical treatments.

Global Cell and Gene Therapy Drug Delivery Devices Market

Growth Drivers

Rising Number of Clinical Trials

The Global Cell and Gene Therapy Drug Delivery Devices Market witnesses substantial growth opportunities, particularly in response to the dynamic landscape of clinical trials. Customizing delivery systems to align with the unique requirements of diverse cell and gene therapies serves as a pivotal strategy to enhance safety, efficacy, and the overall patient experience. The heightened demand for efficient drug delivery devices capable of monitoring dosage during these therapies is a driving force for market expansion. The evolving realm of personalized medicine has heightened the need for cell and gene therapies, consequently fuelling the demand for sophisticated delivery devices. The escalating number of FDA approvals and concurrent clinical trials underscores the industry's dynamic nature and increasing investments in cell therapy and gene therapy, positioning the market for significant growth.

Increasing Prevalence of Chronic Diseases

The Global Cell and Gene Therapy Drug Delivery Devices Market displays substantial potential for industry advancement. The customization of delivery systems to meet the specific demands of diverse cell and gene therapies stands out as an opportunity to elevate safety, efficacy, and overall patient experience. A growing demand for efficient drug delivery devices capable of monitoring dosage during these therapies is anticipated to propel market expansion. The increasing popularity of personalized medicine underscores the need for cell and gene therapies, subsequently driving the demand for compatible delivery devices. The escalating prevalence of chronic diseases, notably cancer, reinforces the critical role of these therapies. Statistics from Globocan 2020 highlight the global surge in cancer cases, aligning with the imperative for advanced therapeutic solutions and corresponding delivery devices.

Restraints

High Cost of Manufacturing System

The growth of the Global Cell and Gene Therapy Drug Delivery Devices Market is hindered by the high cost of manufacturing systems. This financial barrier poses a significant restraint, limiting accessibility and affordability of these advanced therapeutic devices. The intricate manufacturing processes contribute to elevated production expenses, impeding the market's overall growth potential.

Impact of Covid-19 on Global Cell and Gene Therapy Drug Delivery Devices Market

Covid-19 pandemic adversely affected the Global Cell and Gene Therapy Drug Delivery Devices Market. Several factors contributed to this exacerbation, including disruptions in manufacturing and logistics processes, leading to significant complexities in the supply chain of materials. The pandemic prompted the suspension of operations at various clinical centers to mitigate the risk of virus exposure. Shipment delays posed challenges for cell therapies with short shelf lives, requiring timely transportation between manufacturing sites and administration centers. Despite these obstacles, market players shifted their focus to address pandemic-related challenges, with gene therapy companies actively engaging in Covid-19 vaccine research and manufacturing. This pivot resulted in significant expansions in prices and reimbursements for Competitive Generic Therapy (CGTs).

Global Cell and Gene Therapy Drug Delivery Devices Market

Segmental Coverage

Global Cell and Gene Therapy Drug Delivery Devices Market – By Product Type

Based on product type, the Global Cell and Gene Therapy Drug Delivery Devices Market is divided into Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-Filled Syringe, and Infusion Bags segments. The subretinal injection cannula segment holds the highest share in the Global Cell and Gene Therapy Drug Delivery Devices Market by product type. It can be attributed to the growing demand for subretinal injection cannulas, which offer a more efficient and precise approach to ocular drug delivery for cell and gene therapies.

Global Cell and Gene Therapy Drug Delivery Devices Market – By Technology

Based on technology, the Global Cell and Gene Therapy Drug Delivery Devices Market is divided into Microchip Technology, Nanotechnology, and Lipid Nanoparticle segments.

Global Cell and Gene Therapy Drug Delivery Devices Market – By Commercialized Drugs

Based on commercialized drugs, the Global Cell and Gene Therapy Drug Delivery Devices Market is divided into Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, and Strimvelis segments. Luxturna segment holds the highest share in the Global Cell and Gene Therapy Drug Delivery Devices Market by commercialized drugs. Luxturna, represented by voretigene neparvovec-rzyl, is a pioneering gene therapy that directly addresses specific genetic mutations causing retinal dystrophy. It stands out as the first gene therapy approved in the United States for direct administration, focusing on treating confirmed biallelic RPE65 mutation-associated retinal dystrophy. Luxturna's mechanism involves delivering a functional copy of the RPE65 gene directly to retinal cells, utilizing a modified adeno-associated virus as a vector. This innovative approach restores normal protein production, converting light into electrical signals in the retina and effectively addressing vision loss. Due to its groundbreaking nature and successful outcomes in treating a specific genetic disorder, Luxturna has gained prominence and secured a significant share in the market for cell and gene therapy drug delivery devices.

Global Cell and Gene Therapy Drug Delivery Devices Market – By End-User

Based on end-user, the Global Cell and Gene Therapy Drug Delivery Devices Market is divided into Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Hospital & Clinic segments.

Global Cell and Gene Therapy Drug Delivery Devices Market – By Region

The in-depth research report on the Global Cell and Gene Therapy Drug Delivery Devices Market covers the market in a number of key countries across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America region holds the highest share in the Global Cell and Gene Therapy Drug Delivery Devices Market. The region's dominance is attributed to the increasing collaborations between various small and medium enterprises and large conglomerates, aiming to develop affordable and high-quality medicines. Also, the rising occurrences of neurodegenerative issues and the growing demand for finding effective treatments for gene disorders through research, diagnostics, and synthetic biology are significant contributors to the regional market's growth. Within the region, the United States is expected to exhibit the fastest market growth in the forecast years. This is attributed to regulatory bodies like the Centre for Biologics Evaluation & Research (CBER) operating in the country, focusing on cell and gene therapy devices. The CBER provides scientific and regulatory guidance to researchers and manufacturers for the development of new products.

Competitive Landscape

Major players operating in the Global Cell and Gene Therapy Drug Delivery Devices Market include Amgen Inc., Bausch & Lomb Incorporated, Renova Therapeutics, Becton, Dickinson and Company, Bluebird bio-Inc., Castle Creek Biosciences, Inc., Helixmith Co. Ltd, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., and Pfizer Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In April 2023 - AmerisourceBergen unveiled its Cell and Gene Therapy (CGT) Integration Hub, an innovative system designed for seamless integration with biopharma or provider-facing platforms. The platform-agnostic CGT Integration Hub, powered by AmerisourceBergen's CRM system, facilitates real-time data exchange across the cell and gene therapy treatment journey. It aims to enhance connectivity and coordination, offering physicians and patient services teams improved visibility throughout therapy development and delivery.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa 

Product/ Service Segmentation

Product Type, Technology, Commercialized Drugs, End-user, Region

Key Players

Amgen Inc., Bausch & Lomb Incorporated, Renova Therapeutics, Becton, Dickinson and Company, Bluebird bio-Inc., Castle Creek Biosciences, Inc., Helixmith Co. Ltd, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc, Pfizer Inc.

 

By Product Type

  • Subretinal Injection Cannula

  • Extension Tube

  • Intravenous Catheter

  • Sterile Insulin Syringe

  • Pre-Filled Syringe

  • Infusion Bags

By Technology

  • Microchip Technology

  • Nanotechnology

  • Lipid Nanoparticles

By Commercialized Drugs

  • Luxturna

  • Kymriah

  • Yescarta

  • Zolgensma

  • Provenge

  • Strimvelis

By End User

  • Pharmaceutical & Biotechnology Company

  • Academic & Research Institute

  • Hospital & Clinic

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3.  Global Cell and Gene Therapy Drug Delivery Devices Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing prevalence of chronic diseases
        2. Rising number of clinical trials
      2. Restraints
        1. High cost of manufacturing system
        2. Lack of standard therapy protocols
      3. Opportunities
        1. Increasing awareness about the devices among patients and doctors
        2. Rapid growth in investment in cell therapy and gene therapy
      4. Challenges
        1.  Shortage of skilled professionals
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4.  Global Cell and Gene Therapy Drug Delivery Devices Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Thousand)
    2. Market Share and Forecast
      1. By Product Type
        1. Subretinal Injection Cannula
        2. Extension Tube
        3. Intravenous Catheter
        4. Sterile Insulin Syringe
        5. Pre-Filled Syringe
        6.  Infusion Bags
      2. By Technology
        1. Microchip Technology
        2.  Nanotechnology
        3.  Lipid Nanoparticles
      3. By Commercialized Drugs
        1. Luxturna
        2. Kymriah
        3. Yescarta
        4. Zolgensma
        5. Provenge
        6. Strimvelis
      4. By End User
        1. Pharmaceuticals & Biotechnology Company
        2.  Academic & Research Institute
        3.  Hospitals & Clinics
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Cell and Gene Therapy Drug Delivery Devices Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Thousand)
    2. Market Share & Forecast
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End User
      5. By Country
        1. United States
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        2. Canada
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
  6. Europe Cell and Gene Therapy Drug Delivery Devices Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Thousand)
    2. Market Share & Forecast
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End User
      5. By Country
        1. Germany
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        2. United Kingdom
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        3. Italy
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        4. France
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        5. Spain
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        6. Belgium
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        7. Russia
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        8. The Netherlands
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        9. Rest of Europe
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
  7. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Thousand)
    2. Market Share & Forecast
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End User
      5. By Country
        1. China
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        2. India
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        3. Japan
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        4. South Korea
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        5. Australia & New Zealand
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        6. Indonesia
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        7. Malaysia
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        8. Singapore
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        9. Vietnam
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        10. Rest of APAC
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
  8. Latin America Cell and Gene Therapy Drug Delivery Devices Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Thousand)
    2. Market Share & Forecast
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End User
      5. By Country
        1. Brazil
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        2. Mexico
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        3. Argentina
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        4. Peru
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        5. Rest of LATAM
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
  9. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Thousand)
    2. Market Share & Forecast
      1. By Product Type
      2. By Technology
      3. By Commercialized Drugs
      4. By End User
      5. By Country
        1. Saudi Arabia
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        2. UAE
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        3. Qatar
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        4. Kuwait
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        5. South Africa
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        6. Nigeria
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        7. Algeria
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
        8. Rest of MEA
          1. By Product Type
          2. By Technology
          3. By Commercialized Drugs
          4. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Cell and Gene Therapy Drug Delivery Devices Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Cell and Gene Therapy Drug Delivery Devices Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Amgen Inc.
    2. Bausch & Lomb Incorporated
    3. Renova Therapeutics
    4. Becton, Dickinson and Company,
    5. Bluebird bio-Inc.
    6. Castle Creek Biosciences, Inc.
    7. Helixmith Co. Ltd
    8. Kite Pharma Inc.
    9. Kolon TissueGene, Inc.
    10. Novartis AG
    11. Orchard Therapeutics plc.
    12.  Pfizer Inc
    13. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.   Qualitative Research
      1.  Primary & Secondary Research
    2.   Quantitative Research
    3.   Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.   Breakdown of Primary Research Respondents, By Region
    5.   Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

Figure 1       Global Cell and Gene Therapy Drug Delivery Devices Segmentation

Figure 2       Global Cell and Gene Therapy Drug Delivery Devices Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2021

Figure 4       Global Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 5       Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 6       Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 7       Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 8       Global Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 9       Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Region, By Value, 2019-2029

Figure 10     North America Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 11     North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 12     North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 13     North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 14     North America Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 15     North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Figure 16     United States Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 17     United States Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 18     United States Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 19     United States Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 20     United States Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 21     Canada Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 22     Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 23     Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 24     Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 25     Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 26     Europe Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 27     Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 28     Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 29     Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 30     Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 31     Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Figure 32     Germany Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 33     Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 34     Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 35     Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 36     Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 37     United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 38     United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 39     United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 40     United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 41     United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 42     Italy Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 43     Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 44     Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 45     Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 46     Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 47     France Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 48     France Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 49     France Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 50     France Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 51     France Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 52     Spain Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 53     Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 54     Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 55     Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 56     Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By End User, By Value, 2019-2029

Figure 57     Belgium Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 58     Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 59     Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 60     Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 61     Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By End User, By Value, 2019-2029

Figure 62     Russia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 63     Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 64     Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 65     Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 66     Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User, By Value, 2019-2029

Figure 67     The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 68     The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 69     The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 70     The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 71     The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 72     Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 73     Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 74     Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 75     Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 76     Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 77     Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 78     Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 79     Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 80     Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 81     Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 82     Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Figure 83     China Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 84     China Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 85     China Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 86     China Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 87     China Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 88     India Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 89     India Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 90     India Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 91     India Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 92     India Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 93     Japan Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 94     Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 95     Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 96     Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 97     Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 98     South Korea Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 99     South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 100   South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 101   South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 102   South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 103   Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 104   Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 105   Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 106   Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 107   Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 108   Indonesia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 109   Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 110   Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 111   Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 112   Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 113   Malaysia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 114   Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 115   Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 116   Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 117   Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 118   Singapore Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 119   Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 120   Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 121   Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 122   Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 123   Vietnam Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 124   Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 125   Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 126   Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 127   Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 128   Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 129   Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 130   Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 131   Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 132   Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 133   Latin America Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 134   Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 135   Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 136   Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 137   Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 138   Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Figure 139   Brazil Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 140   Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 141   Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 142   Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 143   Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 144   Mexico Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 145   Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 146   Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 147   Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 148   Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 149   Argentina Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 150   Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 151   Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 152   Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 153   Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 154   Peru Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 155   Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 156   Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 157   Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 158   Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 159   Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 160   Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 161   Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 162   Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 163   Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 164   Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 165   Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 166   Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 167   Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 168   Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 169   Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Figure 170   Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 171   Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 172   Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 173   Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 174   Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 175   UAE Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 176   UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 177   UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 178   UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 179   UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 180   Qatar Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 181   Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 182   Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 183   Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 184   Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 185   Kuwait Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 186   Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 187   Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 188   Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 189   Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 190   South Africa Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 191   South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 192   South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 193   South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 194   South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 195   Nigeria Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 196   Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 197   Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 198   Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 199   Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 200   Algeria Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 201   Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 202   Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 203   Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 204   Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Figure 205   Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Figure 206   Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Figure 207   Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Figure 208   Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Figure 209   Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

 

 

List of Tables

 

Table 1        Global Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 2        Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 3 Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 4        Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 5 Global Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 6        Global Cell and Gene Therapy Drug Delivery Devices Market Share, By Region, By Value, 2019-2029

Table 7        North America Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 8        North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 9        North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 10      North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 11      North America Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 12      North America Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Table 13      United States Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 14      United States Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 15      United States Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 16      United States Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 17      United States Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 18      Canada Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 19      Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 20      Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 21      Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 22      Canada Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 23      Europe Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 24      Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 25      Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 26      Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 27      Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 28      Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Table 29      Germany Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 30      Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 31      Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 32      Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 33      Germany Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 34      United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 35      United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 36      United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 37      United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 38      United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 39      Italy Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 40      Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 41      Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 42      Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 43      Italy Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 44      France Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 45      France Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 46      France Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 47      France Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 48      France Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 49      Spain Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 50      Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 51      Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 52      Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 53      Spain Cell and Gene Therapy Drug Delivery Devices Market Share, By End User, By Value, 2019-2029

Table 54      Belgium Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 55      Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 56      Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 57      Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 58      Belgium Cell and Gene Therapy Drug Delivery Devices Market Share, By End User, By Value, 2019-2029

Table 59      Russia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 60      Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 61      Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 62      Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 63      Russia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User, By Value, 2019-2029

Table 64      The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 65      The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 66      The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 67      The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 68      The Netherlands Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 69      Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 70      Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 71      Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 72      Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 73      Rest of Europe Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 74      Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 75      Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 76      Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 77      Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 78      Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 79      Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Table 80      China Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 81      China Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 82      China Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 83      China Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 84      China Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 85      India Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 86      India Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 87      India Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 88      India Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 89      India Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 90      Japan Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 91      Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 92      Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 93      Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 94      Japan Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 95      South Korea Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 96      South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 97      South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 98      South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 99      South Korea Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 100    Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 101    Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 102    Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 103    Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 104    Australia & New Zealand Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 105    Indonesia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 106    Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 107    Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 108    Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 109    Indonesia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 110    Malaysia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 111    Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 112    Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 113    Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 114    Malaysia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 115    Singapore Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 116    Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 117    Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 118    Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 119    Singapore Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 120    Vietnam Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 121    Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 122    Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 123    Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 124    Vietnam Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 125    Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 126    Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 127    Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 128    Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 129    Rest of APAC Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 130    Latin America Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 131    Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 132    Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 133    Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 134    Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 135    Latin America Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Table 136    Brazil Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 137    Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 138    Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 139    Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 140    Brazil Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 141    Mexico Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 142    Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 143    Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 144    Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 145    Mexico Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 146    Argentina Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 147    Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 148    Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 149    Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 150    Argentina Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 151    Peru Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 152    Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 153    Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 154    Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 155    Peru Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 156    Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 157    Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 158    Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 159    Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 160    Rest of LATAM Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 161    Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 162    Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 163    Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 164    Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 165    Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 166    Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Country, By Value, 2019-2029

Table 167    Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 168    Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 169    Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 170    Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 171    Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 172    UAE Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 173    UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 174    UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 175    UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 176    UAE Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 177    Qatar Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 178    Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 179    Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 180    Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 181    Qatar Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 182    Kuwait Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 183    Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 184    Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 185    Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 186    Kuwait Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 187    South Africa Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 188    South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 189    South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 190    South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 191    South Africa Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 192    Nigeria Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 193    Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 194    Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 195    Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 196    Nigeria Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 197    Algeria Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 198    Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 199    Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 200    Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 201    Algeria Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 202    Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Size, By Value (USD Thousand), 2019-2029

Table 203    Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By Product Type, By Value, 2019-2029

Table 204    Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By Technology, By Value, 2019-2029

Table 205    Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By Commercialized Drugs, By Value, 2019-2029

Table 206    Rest of MEA Cell and Gene Therapy Drug Delivery Devices Market Share, By End User Industry, By Value, 2019-2029

Table 207    Amgen Inc. Company Overview

Table 208    Amgen Inc. Financial Overview

Table 209    Bausch & Lomb Incorporated Company Overview

Table 210    Bausch & Lomb Incorporated Financial Overview

Table 211    Renova Therapeutics Company Overview

Table 212    Renova Therapeutics Financial Overview

Table 213    Becton, Dickinson and Company, Company Overview

Table 214    Becton, Dickinson and Company, Financial Overview

Table 215    Bluebird bio-Inc. Company Overview

Table 216    Bluebird bio-Inc. Financial Overview

Table 217    Castle Creek Biosciences, Inc. Company Overview

Table 218    Castle Creek Biosciences, Inc. Financial Overview

Table 219    Helixmith Co. Ltd Company Overview

Table 220    Helixmith Co. Ltd Financial Overview

Table 221    Kite Pharma Inc. Company Overview

Table 222    Kite Pharma Inc. Financial Overview

Table 223    Kolon TissueGene, Inc. Company Overview

Table 224    Kolon TissueGene, Inc. Financial Overview

Table 225    Novartis AG Company Overview

Table 226    Novartis AG Financial Overview

Table 227    Orchard Therapeutics plc. Company Overview

Table 228    Orchard Therapeutics plc. Financial Overview

Table 229    Pfizer Inc Company Overview

Table 230    Pfizer Inc Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Global Cell and Gene Therapy Drug Delivery Devices Market size was estimated at USD 99.97 thousand in 2022.
Ans: Global Cell and Gene Therapy Drug Delivery Devices Market size is expected to grow at a CAGR of 16.79% during the forecast period between 2023 and 2029.
Ans: Global Cell and Gene Therapy Drug Delivery Devices Market size is expected to reach a value of USD 253.69 thousand by 2029.
Ans: Major factors driving the growth of the Global Cell and Gene Therapy Drug Delivery Devices Market include an increasing prevalence of chronic diseases and rising number of clinical trials.
Ans: North America holds the highest market share in the Global Cell and Gene Therapy Drug Delivery Devices Market.
Ans: The Luxturna segment accounts for the highest market share in the Global Cell and Gene Therapy Drug Delivery Devices Market by commercialized drug.
Ans: The subretinal injection cannula segment holds the highest market share in the Global Cell and Gene Therapy Drug Delivery Devices Market by product type.
Ans: Key players in the Global Cell and Gene Therapy Drug Delivery Devices Market include Amgen Inc., Bausch & Lomb Incorporated, Renova Therapeutics, Becton, Dickinson and Company, Bluebird bio-Inc., Castle Creek Biosciences, Inc., Helixmith Co. Ltd, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., and Pfizer Inc.